New York, United States, May 02, 2022 (GLOBE NEWSWIRE) -- The global Fetal Bovine Serum market was valued at USD 879.9 million in 2021, according to the new report of Straits Research. It is predicted to increase at a CAGR of 5.69% from 2022 to 2030. Fetal bovine serum (FBS) is used in cell culture media by academic and industry researchers and scientists in manufacturing contexts for studies such as biotechnology research/production, vaccine manufacturing, cloning, and animal diagnostics. Growth factors, proteins, trace minerals, vitamins, and hormones are all present in fetal bovine serum, a complex collection of biomolecules.
Key Insights
- The fetal bovine serum market was valued at USD 879.9 million in 2021 and is anticipated to generate USD 1401.23 million by 2030, growing at a CAGR of 5.69%.
- By types, the market is divided into charcoal stripped, stem cells, dialyzed, inactivated, and others. The stem cells thruster has acquired the largest market share in 2021 out of all the segments.
- Based on application, the market is segmented into drug discovery, cell culture, immunoassay, and others. In 2021, the cell culture segment acquired 38.45% of the market share.
- Based on end-user, the market is segmented as research and academic institutions, diagnostics labs, pharmaceuticals, and other industries.
- America and Europe are the two of the most dominant markets for fetal bovine serum. These markets are expected to grow at a CAGR of 4.78% and 4.45%, respectively.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/fetal-bovine-serum-market/request-sample
Increasing application in Cell-based Pharmaceutical Research to Upsurge the Fetal Bovine Serum Market
During the last decades, the demand for new drugs has increased. Cell-based screening is the screening under the living cell's background, which delivers more effective and comprehensive information about drugs' mechanism and mode of action. Many different technologies have emerged and are used for cell-based screening and profiling. Fetal bovine serum is widely used in research and development activities. It exceeds cell culture testing standards and is used to promote growth medium. It is used in the research in cell culture medium growth, including biotechnology research, vaccine production, cloning, and in vitro fertilization.
Pharmaceutical research is an expensive activity overall, the use of fetal bovine serum reduces the cost accrued in research. Additionally, it has various advantages, such as a high quantity of hormones, carrier proteins, and macromolecular proteins, which improve the growth of the cells. Vaccines such as Varivax III, a vaccine that protects against varicella virus, and MMRII are produced using the fetal bovine serum as a cell culture growth medium.
Impact of COVID-19
On January 30, 2020, the World Health Organization (WHO) announced the COVID-19 outbreak, a global public health emergency. COVID-19 has affected approximately 210 nations. Governments worldwide have issued country-wide lockdowns and social distancing measures in response to the COVID-19 pandemic to prevent the healthcare system from collapsing. Governments have often imposed limitations and bans on medical procedures and elective surgery. These restrictions continue to hinder the growth of many businesses, and the outbreak's immediate impact differs by industry.
Due to the global implementation of lockdown, the distribution, production, and supply chain have all been impacted. Fetal bovine serum-based VTM has shown to be compatible with various clinical assays, including PCR, direct antigen testing, and culture, allowing many tests to be performed on the same sample. As a result, the market for fetal bovine serum is predicted to expand rapidly.
Buy Now Full Report @ https://straitsresearch.com/buy-now/fetal-bovine-serum-market/global/
Global Fetal Bovine Serum Market: Segmentation
By Types
- Charcoal Stripped
- Stem Cells
- Dialyzed
- Inactivated
- Others
By Application
- Drug Discovery
- Cell Culture
- Immunoassay
- Others
By End-User
- Research and Academic Institutions
- Diagnostics Labs
- Pharmaceuticals
- Others
By Regions
- North America
- Europe
- Asia-Pacific
- LAMEA
List of Key Players
- GE Healthcare
- Thermo Fisher Scientific Inc.
- Merck (Sigma Aldrich) Corporation
- Biowest
- Peak Serum
- Biological Industries
- Tissue Culture Biologicals
- RMBIO
- PAN-Biotech GmbH
- Bovogen Biologicals Pty. Ltd
- Nucleus Biologics
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/fetal-bovine-serum-market/request-sample
Detailed Table of Content
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions and Exclusions
2.4 Secondary Data Sources
3 Executive Summary
4 Market Overview
4.1 Report Segmentation and Scope
4.2 Key Market Trends
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porter’s Five Forces Analysis
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Buyers
4.3.3 Threat of Substitution
4.3.4 Threat of New Entrants
4.3.5 Competitive Rivalry
4.4 Environment and Regulatory Landscape
4.5 Macro-Economic and Geopolitical Scenario
4.6 Parent Market Overview
4.7 Technology Landscape
5 Products Overview
5.1 Introduction
5.1.1 Market Size and Forecast
5.2 Charcoal Stripped
5.2.1 Market Size and Forecast
5.3 Chromatographic
5.3.1 Market Size and Forecast
5.4 Dialyzed Fetal Bovine Serum
5.4.1 Market Size and Forecast
5.5 Exosome Depleted
5.5.1 Market Size and Forecast
5.6 Stem Cell
5.6.1 Market Size and Forecast
5.6.2 Embryonic Stem Cells Qualified
5.6.3 Mesenchymal Stem Cell Qualified
5.7 Others
5.7.1 Market Size and Forecast
6 Applications Overview
6.1 Introduction
6.1.1 Market Size and Forecast
6.2 Drug Discovery
6.2.1 Market Size and Forecast
6.3 Cell Culture Media
6.3.1 Market Size and Forecast
6.4 In-vitro Fertilization
6.4.1 Market Size and Forecast
6.5 Human and Animal Vaccine production
6.5.1 Market Size and Forecast
6.6 Diagnostics
6.6.1 Market Size and Forecast
6.7 Others
6.7.1 Market Size and Forecast
7 End-Users Overview
7.1 Introduction
7.1.1 Market Size and Forecast
7.2 Pharmaceutical Companies
7.2.1 Market Size and Forecast
7.3 Biotechnology and Biopharmaceuticals
7.3.1 Market Size and Forecast
7.4 Research and Academic Institutes
7.4.1 Market Size and Forecast
7.5 Contract Research Organizations (CROs)
7.5.1 Market Size and Forecast
7.6 Others
7.6.1 Market Size and Forecast
8 Regional Overview
8.1 Introduction
8.1.1 Market Size and Forecast
8.2 Americas
8.2.1 Economic Overview
8.2.2 Market Scenario
8.2.3 North America
8.2.3.1 By Products
8.2.3.2 By Applications
8.2.3.3 By End-Users
8.2.4 The U.S.
8.2.4.1 By Products
8.2.4.2 By Applications
8.2.4.3 By End-Users
8.2.5 Canada
8.2.5.1 By Products
8.2.5.2 By Applications
8.2.5.3 By End-Users
8.2.6 South America
8.2.6.1 By Products
8.2.6.2 By Applications
8.2.6.3 By End-Users
8.3 Europe
8.3.1 Economic Overview
8.3.2 Market Scenario
8.3.3 Germany
8.3.3.1 By Products
8.3.3.2 By Applications
8.3.3.3 By End-Users
8.3.4 France
8.3.4.1 By Products
8.3.4.2 By Applications
8.3.4.3 By End-Users
8.3.5 The U.K.
8.3.5.1 By Products
8.3.5.2 By Applications
8.3.5.3 By End-Users
8.3.6 Italy
8.3.6.1 By Products
8.3.6.2 By Applications
8.3.6.3 By End-Users
8.3.7 Spain
8.3.7.1 By Products
8.3.7.2 By Applications
8.3.7.3 By End-Users
8.3.8 The Rest of Europe
8.3.8.1 By Products
8.3.8.2 By Applications
8.3.8.3 By End-Users
8.4 Asia-Pacific (APAC)
8.4.1 Economic Overview
8.4.2 Market Scenario
8.4.3 China
8.4.3.1 By Products
8.4.3.2 By Applications
8.4.3.3 By End-Users
8.4.4 Japan
8.4.4.1 By Products
8.4.4.2 By Applications
8.4.4.3 By End-Users
8.4.5 India
8.4.5.1 By Products
8.4.5.2 By Applications
8.4.5.3 By End-Users
8.4.6 Australia
8.4.6.1 By Products
8.4.6.2 By Applications
8.4.6.3 By End-Users
8.4.7 South Korea
8.4.7.1 By Products
8.4.7.2 By Applications
8.4.7.3 By End-Users
8.4.8 Rest of APAC
8.4.8.1 By Products
8.4.8.2 By Applications
8.4.8.3 By End-Users
8.5 The Middle East and Africas
8.5.1 Economic Overview
8.5.2 Market Scenario
8.5.3 Middle East
8.5.3.1 By Products
8.5.3.2 By Applications
8.5.3.3 By End-Users
8.5.4 Africas
8.5.4.1 By Products
8.5.4.2 By Applications
8.5.4.3 By End-Users
9 Competitive Landscape — Manufacturers and Suppliers
9.1 Competition Dashboard
9.2 Market Share Analysis
9.3 Key Developments and Movements
9.4 Consolidated SWOT Analysis of Key Players
10 Company Profiles
10.1 Thermo Fisher Scientific Inc.
10.1.1 Business Overview
10.1.2 Financial Performance
10.1.3 Recent Developments
10.1.4 Product Portfolio
10.2 Merck KGaA
10.2.1 Business Overview
10.2.2 Financial Performance
10.2.3 Recent Developments
10.2.4 Product Portfolio
10.3 Atlanta Biologicals Inc.
10.3.1 Business Overview
10.3.2 Financial Performance
10.3.3 Recent Developments
10.3.4 Product Portfolio
10.4 Tissue Culture Biologicals
10.4.1 Business Overview
10.4.2 Financial Performance
10.4.3 Recent Developments
10.4.4 Product Portfolio
10.5 HiMedia laboratories
10.5.1 Business Overview
10.5.2 Financial Performance
10.5.3 Recent Developments
10.5.4 Product Portfolio
11 Conclusion and Recommendation
12 Acronyms and Abbreviations
For More Information, TOC, Query or Customization Before Buying, Visit @ https://straitsresearch.com/report/fetal-bovine-serum-market/toc
Market News
- Merck KgAA has announced a EUR 28 million (equivalent to USD 26.8 million) investment to expand a single-use assembly production line at its Life Science Center in Molsheim, France, in March 2021.
- In July 2017, GE Healthcare and Oritain launched a testing service for combating serum fraud.
News
Increasing Application in Cell Culture Likely to Escalate the Fetal Bovine Serum Market
Trending Reports
Biopharmaceutical Logistics Market: Information by Supply Chain (Cold Chain and Non-Cold Chain), Type of Services (Transportation, Warehousing), and Region — Forecast till 2026
Gene Therapy Cell Culture Media Market: Information by Type (Stem Cell Culture Media, Serum-Free Media), End-User (Pharma and Biotech Companies), and Region — Forecast till 2029
Drug Discovery Service Market: Information by Type (Pharmacokinetics), Process (Target Validation), Drug Type, Therapeutic Area, End User (Pharmaceutical Companies),and Region — 2020-2029
About Straits Research Pvt. Ltd.
StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
So let us put our minds together. We will make your vision a reality and help you grow.
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: sales@straitsresearch.com
LinkedIn: https://www.linkedin.com/company/straitsresearch/
Facebook: https://www.facebook.com/straitsresearch/
Instagram: https://www.instagram.com/straitsresearch/
